WOBURN, Mass., Nov. 13, 2018 /PRNewswire/ — Bio2 Technologies, Inc., a privately held orthopedics company, announced today that it received U.S. Food and Drug Administration (“FDA”) approval to begin enrollment in an IDE clinical study to evaluate Vitrium as a cervical interbody fusion device.  Vitrium will be evaluated as a structural device that facilitates bone remodeling via a […]